He will be joined by Louise Mawhinney, CPA, Chief Financial Officer, and Linda Rhodes, V.M.D., Ph.D., Chief Scientific Officer of Aratana Therapeutics. About Aratana Therapeutics Aratana Therapeutics is a biopharmaceutical company positioned to deliver high quality new medicines that address significant therapeutic needs for cats and dogs (companion animals). Aratana licenses and develops proprietary, patent-protected compounds acquired from human pharmaceutical and biotechnology companies and then develops strategies to maximize the value of the programs for the animal health market. For more information, please visit www.aratanatherapeutics.com. For Media & Investors: Jason Rando / Joshua Drumm, Ph.D. Tiberend Strategic Advisors, Inc. (212) 827-0020 SOURCE Aratana Therapeutics